The data on low population incidence and RCC-specific penetrance [127] are in apparent conflict with the results of a multigene sequencing study, which revealed FH pathogenic or likely pathogenic variants in 7/254 (2.8%) RCC patients [9]. This evidence concerns the gene FH and renal cell adenocarcinoma.